{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T23:26:18Z","timestamp":1768433178240,"version":"3.49.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"C","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T00:00:00Z","timestamp":1487721600000},"content-version":"vor","delay-in-days":52,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>INTRODUCTION:<\/jats:title>\n                    <jats:p>Proton pump inhibitor (PPI) use is associated with the development of fundic gland polyps (FGPs); discontinuing PPIs is associated with regression of FGPs. Here, we report a rare case of non-respondent FGPs after discontinuation of PPI that were successfully treated using an argon plasma coagulator (APC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PRESENTATION OF CASE:<\/jats:title>\n                    <jats:p>We present the case of a 68-year-old woman with a history of polycytheamia vera. She also had gastroesophageal reflux disease (GERD) and had been taking 10 mg of omeprazole daily for the past three years. Esophagogastroduedenoscopy (GF) revealed over 100 pedunculated polyps in the gastric body and fundus. Histological examination of the specimens showed dilated oxyntic glands with flattened parietal and mucous cells. Based on these findings and the clinical history, a diagnosis of FGPs was made. Omeprazole use was then discontinued. Repeat GF performed 6 months and 1 year later showed a significant increase in the number and size of the polyps. APC treatment was performed every 6 months for 3 years. Further GF showed a significant decrease in the number and size of the FGPs 4 years after discontinuing PPI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DISCUSSION:<\/jats:title>\n                    <jats:p>We conclude that PPI use is a strong risk factor for the development of FGPs and discontinuing PPI is associated with regression of FGPs, but not in patients with polycythaemia vera. However, the mechanism involved in the interaction between FGP and polycytheamia vera remains unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Non-respondent FGPs after discontinuation of PPI use may be successfully treated using APC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Highlights<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1016\/j.ijscr.2017.02.039","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T03:22:20Z","timestamp":1487906540000},"page":"75-78","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Successful treatment of proton pump inhibitor induced sporadic fundic gland polyps with an argon plasma coagulator in a patient with polycythaemia vera"],"prefix":"10.1097","volume":"33","author":[{"given":"Kazuya","family":"Kato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Onodera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takako","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mineko","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimitaka","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yurina","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Tamakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-21-20260114","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1038\/ajg.2009.139","article-title":"The current spectrum of gastric polyps: a 1-year national study of over 120,000 patients","volume":"104","author":"Camack","year":"2009","journal-title":"Am. J. Gastroenterol"},{"key":"R2-21-20260114","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/j.1365-2036.2006.03127.x","article-title":"Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy","volume":"24","author":"Jalving","year":"2006","journal-title":"Aliment. Pharmacol. Ther"},{"key":"R3-21-20260114","first-page":"192","article-title":"Dysplastic changes in gastric fundic polyps of patients with familiar adenomatous polyposis","volume":"31","author":"Bertoni","year":"1999","journal-title":"Ital. J. Gatroenterol. Hepatol"},{"key":"R4-21-20260114","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijsu.2016.08.014","article-title":"The SCARE statement: consensus-based surgical case report guidelines","volume":"34","author":"Agha","year":"2016","journal-title":"Int. J. Surg"},{"key":"R5-21-20260114","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/S0002-9440(10)64450-1","article-title":"Sporadic fundic gland polyps with epithelial dysplasia: evidence for preferential targeting for mutations in the adenomatous polyposis coli gene","volume":"161","author":"Abraham","year":"2002","journal-title":"Am. J. Pathol"},{"key":"R6-21-20260114","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/01.MP.0000018976.15044.9B","article-title":"Sporadic fundic gland polyposis: a clinical, histological, and molecular analysis","volume":"15","author":"Torbenson","year":"2002","journal-title":"Mod. Pathol"},{"key":"R7-21-20260114","first-page":"1241","article-title":"Morules in fundic gland polypsis: a case report","volume":"7","author":"Petris","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol"},{"key":"R8-21-20260114","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1007\/BF02093608","article-title":"Omeprazole produces partial cell hypertrophy and hyperplasia in humans","volume":"41","author":"Driman","year":"1996","journal-title":"Dig. Dis. Sci"},{"key":"R9-21-20260114","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3164\/jcbn.2008028","article-title":"Gastric epithelial cell modality and proton pump inhibitor","volume":"42","author":"Masaoka","year":"2008","journal-title":"J. inhibitor. Clin. Biochem. Nutr"},{"key":"R10-21-20260114","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/00365520701561959","article-title":"Serum gastrin and chromogranin level in patients with fundic gland polyps caused by long-term proton pump inhibition","volume":"43","author":"Fossmark","year":"2008","journal-title":"Scand. J. Gasroenterol"},{"key":"R11-21-20260114","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s00535-010-0207-7","article-title":"Incidence and risk factor of fundic gland polyps and hyperplastic polyps in long-term proton pump inhibitor therapy: a prospective study in Japan","volume":"45","author":"Hongo","year":"2010","journal-title":"J. Gastroenterol"},{"key":"R12-21-20260114","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1007\/s10620-010-1493-x","article-title":"Fundic gland polyps and association with proton pump inhibitor intake: a prospective study in 1,780 endoscopies","volume":"56","author":"Zelter","year":"2011","journal-title":"Dig. Dis. Sci"},{"key":"R13-21-20260114","first-page":"305","article-title":"Spontaneous resolution of multiple fundic gland polyps after cessation of treatment with omeprazole","volume":"51","author":"Kim","year":"2008","journal-title":"Korean J. Gastroenterol"},{"key":"R14-21-20260114","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nrgastro.2009.70","article-title":"Management of gsatric polyps: a pathology-based guide for gastroenterologists","volume":"6","author":"Carmacks","year":"2009","journal-title":"Nat. Rev. Gastroenterol. Hepatol"},{"key":"R15-21-20260114","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.cgh.2013.03.019","article-title":"Manegement of gastric polyps: an endoscopic approach","volume":"11","author":"Shaib","year":"2013","journal-title":"Clin. Gastroentol. Hepatol"},{"key":"R16-21-20260114","first-page":"352","article-title":"The tissue effect of second generation argon plasma coagulation (VIO APC) in comparison to standard APC and Nd: YAG laser in vitro","volume":"70","author":"Mnnar","year":"2007","journal-title":"Acta Gastroenterol. Belg"},{"key":"R17-21-20260114","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1067\/mge.2000.108412","article-title":"The tissue effect of argon plasma coagulation on esophageal and gastric mucosa","volume":"52","author":"Watson","year":"2000","journal-title":"Gastrointest. Endosc"},{"key":"R18-21-20260114","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/00042737-199706000-00006","article-title":"Argon plasma coagulation (APC) in gastroenterology experimental and clinical experience","volume":"9","author":"Johanns","year":"1997","journal-title":"Eur. J. Gastroenterol. Hepatol"},{"key":"R19-21-20260114","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1067\/mge.2002.121597","article-title":"Treatment of argon plasma coagulation reduces recurrence after piecemeal resection of large sessile colonic polyps: a randomized trial and recommendations","volume":"55","author":"Brooker","year":"2002","journal-title":"Gasrointest. Endosc"},{"key":"R20-21-20260114","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1046\/j.1365-2141.2002.03380.x","article-title":"Gastroduodenal lesions in polycythaemia vera: frequency and role of helicobactor pylori","volume":"117","author":"Torgano","year":"2002","journal-title":"Br. J. Haematol"}],"container-title":["International Journal of Surgery Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261217301116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261217301116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01612930-201733000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T13:02:19Z","timestamp":1768395739000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01612930-201733000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":20,"journal-issue":{"issue":"C","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1016\/j.ijscr.2017.02.039","relation":{},"ISSN":["2210-2612"],"issn-type":[{"value":"2210-2612","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}